First‐Line Osimertinib for EGFR‐Mutated Squamous Cell Lung Carcinoma: A Case Report

ABSTRACT Background Epidermal growth factor receptor (EGFR) mutations in squamous cell lung carcinoma are rare. EGFR‐tyrosine kinase inhibitors are generally less effective for EGFR‐mutated squamous cell lung carcinoma. We herein present a case of EGFR‐mutated squamous cell lung carcinoma that respo...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Yugo Matsumura, Seiya Ichihara, Kaori Nii, Kazumasa Nanjo, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Hiroyuki Hino, Keishi Naruse, Tsutomu Shinohara, Shoji Sakiyama, Eiji Tacheuchi
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Wiley 2025-07-01
श्रृंखला:	Cancer Reports
विषय:	EGFR mutation EGFR‐TKI L858R osimertinib squamous cell lung cancer
ऑनलाइन पहुंच:	https://doi.org/10.1002/cnr2.70273
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!